Reflections on the IJHPR’s article collection on dementia
October 6, 2020
Continue reading
News
IMPACT members discuss the importance of comprehensive dementia care
Editorial: How Do We Make Comprehensive Dementia Care a Benefit?
September 25, 2020
IMPACT Collaboratory funds two career development awards
The National Institute on Aging (NIA) Imbedded Pragmatic AD/ADRD Clinical Trials (IMPACT) Collaboratory is pleased to announce the recipients of its inaugural cycle of the IMPACT Career Development Award Program. Recipients were selected from an impressive group of competitive applications.
2020 IMPACT Career Development Award Recipients
Jennifer Gabbard, MD, Wake Forest School of Medicine
Use of a dementia-specific portal-based tool for advance care planning engagement
Tina Sadarangani, PhD, RN, ANP-BC, GNP-BC, NYU Rory Meyers College of Nursing
Leveraging mHealth to reduce avoidable utilization by people with dementia in day centers
About the NIA IMPACT Career Development Award Program
NIA IMPACT Collaboratory funds two to three career development awards annually. These career development awards will support the development of early-stage MD, PhD, or equivalent researchers who seek careers conducting ePCTs for people living with AD/ADRD and their care partners. The IMPACT Collaboratory prioritizes applications that address dementia care for people of all backgrounds and promote health equity.
Conducting ePCTs in AD/ADRD within healthcare systems requires unique research skills, yet the field is relatively nascent. The number of investigators capable of rigorously designing and executing ePCTs in partnership with healthcare systems and other key stakeholders remains limited, and those that have intersecting expertise in AD/ADRD populations are even fewer. Thus, the career development award advances the IMPACT Collaboratory’s mission to build the nation’s capacity to conduct impactful ePCTs in AD/ADRD by training a workforce of investigators prepared to carry on this work well into the future.
Please join our mailing list to receive news and invitations to IMPACT events, Grand Rounds, and pragmatic trials training modules.
Learn more about the IMPACT Collaboratory on our website, Twitter and LinkedIn.
IMPACT-C to develop and evaluate equitable and compassionate COVID-19 testing strategies in skilled nursing facilities
The National Institutes of Health has awarded nearly $234 million to improve COVID-19 testing for underserved and vulnerable populations. A part of the Rapid Acceleration of Diagnostics (RADx) initiative, the RADx Underserved Populations (RADx-UP) program will support 32 institutions across the United States and will focus on populations disproportionately affected by the pandemic.
IMPACT Principal Investigator Vince Mor, PhD and Sarah Berry, MD from Hebrew Senior Life received a RADx-UP award for Improved Testing for COVID-19 in Skilled Nursing Facilities. IMPACT-C is a collaborative initiative to develop and evaluate equitable and compassionate SARS-CoV-2 testing strategies in vulnerable patients and workers within skilled nursing facilities.
New IMPACT Resources now available
The IMPACT Knowledge Repository (KR) and Pragmatic Trials Training Modules are now available within IMPACT Resources.
The KR is a searchable collection of IMPACT resources including all publications, podcasts, grand rounds, videos and training modules developed by IMPACT members and cores. The IMPACT Pragmatic Trials Training Modules are a series of short videos produced by content experts introducing important considerations for conducting embedded pragmatic clinical trials with people living with Alzheimer’s Disease and related dementias and their care partners.
New IMPACT Funding Opportunity: Pilot Grant Program RFA Cycle 2B
The National Institute on Aging (NIA) IMbedded Pragmatic Alzheimer’s disease (AD) and AD-Related Dementias (AD/ADRD) Clinical Trials (IMPACT) Collaboratory has released a new funding opportunity available for investigators interested in developing embedded pragmatic clinical trials (ePCTs) in dementia research.
Detailed information about the program as well as timelines, eligibility, and other requirements are provided below and in the request for applications (RFAs). Updates will be posted to IMPACT Pilot Grant Program webpage.
Pilot Grant Program RFA Cycle 2B
The IMPACT Collaboratory is soliciting letters of intent for several 1-year pilot awards for up to $175,000 in direct costs. The goal of these awards is to support pilot studies to generate the preliminary data necessary to design and conduct future full-scale ePCTs of non-pharmacologic interventions in health care systems for people living with AD/ADRD and/or their care partners. The mandatory letter of intent is due September 18, 2020.
The IMPACT Collaboratory will consider applications for pilot ePCTs testing non-pharmacological interventions in people living with AD/ADRD and their care partners. In this grant cycle, the IMPACT Collaboratory will consider all applications that propose pilot ePCTs for people living with AD/ADRD and their care partners but will prioritize those in the following areas:
- Interventions that strive to reduce inequities in health care experienced by minority, underserved, or disadvantaged populations or in settings serving a disproportionate share of minority, underserved, or disadvantaged populations;
- Interventions that strive to address social isolation and loneliness; and
- Interventions that use telemedicine, telehealth, and remote technologies to improve health, unmet needs, quality of life and/or health outcomes.
The IMPACT Collaboratory will fund up to five 1-year, non-renewable pilot grant awards for up to $175,000 in direct costs. Letters of intent are required and due September 18, 2020. Full proposal applications are by invitation only and will be due January 8, 2021. For further details, please see the on the IMPACT Pilot Grant Program webpage.
Two optional informational webinars will provide investigators with an overview of application details and support that the IMPACT Collaboratory can provide to assist with proposal development (e.g., trial design, measurement, data extraction, etc.). Investigators will have the opportunity to ask questions. Pre-registration is required using the links below.
- Wednesday, August 26, 2020 at 2:00 pm ET: Registration closed.
- Tuesday, September 8, 2020 at 4:00 pm ET: Registration closed.
Registrants will receive a confirmation email containing information to join the webinar.
The IMPACT Collaboratory encourages all eligible researchers to take advantage of this important funding opportunity, which has the potential to advance care for people living with dementia and/or their care partners in real-world settings. For more information about the IMPACT Collaboratory, please visit impactcollaboratory.org.
The NIA IMPACT Collaboratory is supported through funding from the National Institute on Aging (U54AG063546).
